Build Your Portfolio Around This Stock
This industry leader is positioned to take more market share.
Compass’ IPO Valuation Is Off the Map
SoftBank needs this IPO more than investors do.
More Sector & Industry-Level Research for Clients
Platinum-and-higher members get access to our more reliable sector & industry research.
The Importance of Reading Footnotes: Gilead Sciences
Recapping hidden gains/losses that materially distort earnings. Buyer beware.
Featured Stock in Dividend Growth Stocks Model Portfolio
Get a free look at one of the stocks in this month's model portfolio.
Danger Zone Podcast: 3/22/21: Why This Fund Isn't What It Seems
Our holdings research reveals more danger than traditional research.
Upcoming Research
- New Danger Zone: 4/5/21
- New Long Idea: 4/7/21
- Most Attractive/Most Dangerous: Model Portfolio Update: 4/7/21
- Exec Comp Aligned with ROIC: Model Portfolio Update: 4/15/21
Coverage Updates
- 104: 10-Qs parsed since Mar 1.
- 1,112: 10-Ks parsed since Mar 1.
- 53: stocks, ETFs & mutual funds added to coverage universe over the last 3 months.
- 12: IPOs added to coverage universe over the last 3 months.